CoChat

Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response

Open access
Pulloor, Niyas Kudukkil, Nair, Sajith, Kostic, Aleksandar D., Bist, Pradeep, Weaver, Jeremy D., Riley, Andrew M., Tyagi, Richa, Uchil, Pradeep D., York, John D., Snyder, Solomon H., García-Sastre, Adolfo, Potter, Barry V. L., Lin, Rongtuan, Shears, Stephen B., Xavier, Ramnik J., Krishnan, Manoj N. · 2014 · PLoS Pathogens
Cited by 72

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

The pattern recognition receptor RIG-I is critical for Type-I interferon production. However, the global regulation of RIG-I signaling is only partially understood. Using a human genome-wide RNAi-screen, we identified 226 novel regulatory proteins of RIG-I mediated interferon-β production. Furthermore, the screen identified a metabolic pathway that synthesizes the inositol pyrophosphate 1-IP7 as a previously unrecognized positive regulator of interferon production. Detailed genetic and biochemical experiments demonstrated that the kinase activities of IPPK, PPIP5K1 and PPIP5K2 (which convert IP5 to1-IP7) were critical for both interferon induction, and the control of cellular infection by Sendai and influenza A viruses. Conversely, ectopically expressed inositol pyrophosphate-hydrolases DIPPs attenuated interferon transcription. Mechanistic experiments in intact cells revealed that the expression of IPPK, PPIP5K1 and PPIP5K2 was needed for the phosphorylation and activation of IRF3, a transcription factor for interferon. The addition of purified individual inositol pyrophosphates to a cell free reconstituted RIG-I signaling assay further identified 1-IP7 as an essential component required for IRF3 activation. The inositol pyrophosphate may act by β-phosphoryl transfer, since its action was not recapitulated by a synthetic phosphonoacetate analogue of 1-IP7. This study thus identified several novel regulators of RIG-I, and a new role for inositol pyrophosphates in augmenting innate immune responses to viral infection that may have therapeutic applications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1003981

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 67

  1. H Kumar, 2009, Pathogen recognition in the innate immune response, Biochem J, 420, 1, 10.1042/BJ20090272 · DOI · Paper page
  2. SY Liu, 2011, New developments in the induction and antiviral effectors of type I interferon, Curr Opin Immunol, 23, 57, 10.1016/j.coi.2010.11.003 · DOI · Paper page
  3. M Yoneyama, 2010, Recognition of viral nucleic acids in innate immunity, Rev Med Virol, 20, 4, 10.1002/rmv.633 · DOI · Paper page
  4. SM Belgnaoui, 2011, Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter, Curr Opin Immunol, 23, 564, 10.1016/j.coi.2011.08.001 · DOI · Paper page
  5. HJ Ramos, 2011, RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity, Curr Opin Virol, 1, 167, 10.1016/j.coviro.2011.04.004 · DOI · Paper page
  6. RB Seth, 2006, Antiviral innate immunity pathways, Cell Res, 16, 141, 10.1038/sj.cr.7310019 · DOI · Paper page
  7. M Yoneyama, 2004, The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses, Nat Immunol, 5, 730, 10.1038/ni1087 · DOI · Paper page
  8. J Hiscott, 1999, Triggering the interferon response: the role of IRF-3 transcription factor, J Interferon Cytokine Res, 19, 1, 10.1089/107999099314360 · DOI · Paper page
  9. R Lin, 1999, Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains, Mol Cell Biol, 19, 2465, 10.1128/MCB.19.4.2465 · DOI · Paper page
  10. W Suhara, 2000, Analyses of virus-induced homomeric and heteromeric protein associations between IRF-3 and coactivator CBP/p300, J Biochem, 128, 301, 10.1093/oxfordjournals.jbchem.a022753 · DOI
  11. MU Gack, 2007, TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity, Nature, 446, 916, 10.1038/nature05732 · DOI · Paper page
  12. X Jiang, 2012, Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response, Immunity, 36, 959, 10.1016/j.immuni.2012.03.022 · DOI · Paper page
  13. HM Liu, 2012, The mitochondrial targeting chaperone 14-3-3epsilon regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity, Cell Host Microbe, 11, 528, 10.1016/j.chom.2012.04.006 · DOI · Paper page
  14. H Oshiumi, 2010, The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection, Cell Host Microbe, 8, 496, 10.1016/j.chom.2010.11.008 · DOI · Paper page
  15. T Saitoh, 2006, Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1, Nat Immunol, 7, 598, 10.1038/ni1347 · DOI · Paper page
  16. GA Versteeg, 2013, The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors, Immunity, 38, 384, 10.1016/j.immuni.2012.11.013 · DOI · Paper page
  17. E Wies, 2013, Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling, Immunity, 38, 437, 10.1016/j.immuni.2012.11.018 · DOI · Paper page
  18. C Munk, 2011, Systems-biology approaches to discover anti-viral effectors of the human innate immune response, Viruses, 3, 1112, 10.3390/v3071112 · DOI
  19. JL Gardy, 2009, Enabling a systems biology approach to immunology: focus on innate immunity, Trends Immunol, 30, 249, 10.1016/j.it.2009.03.009 · DOI
  20. SD Shapira, 2009, A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection, Cell, 139, 1255, 10.1016/j.cell.2009.12.018 · DOI · Paper page
  21. MS Suthar, 2013, A systems biology approach reveals that tissue tropism to West Nile virus is regulated by antiviral genes and innate immune cellular processes, PLoS Pathog, 9, e1003168, 10.1371/journal.ppat.1003168 · DOI
  22. FS Menniti, 1993, Turnover of inositol polyphosphate pyrophosphates in pancreatoma cells, J Biol Chem, 268, 3850, 10.1016/S0021-9258(18)53551-1 · DOI · Paper page
  23. L Stephens, 1993, The detection, purification, structural characterization, and metabolism of diphosphoinositol pentakisphosphate(s) and bisdiphosphoinositol tetrakisphosphate(s), J Biol Chem, 268, 4009, 10.1016/S0021-9258(18)53571-7 · DOI · Paper page
  24. MM Tsui, 2010, Roles of inositol phosphates and inositol pyrophosphates in development, cell signaling and nuclear processes, Adv Enzyme Regul, 50, 324, 10.1016/j.advenzreg.2009.12.002 · DOI · Paper page
  25. RS Jadav, 2013, Inositol pyrophosphate synthesis by inositol hexakisphosphate kinase 1 is required for homologous recombination repair, J Biol Chem, 288, 3312, 10.1074/jbc.M112.396556 · DOI · Paper page
  26. MA Koldobskiy, 2010, p53-mediated apoptosis requires inositol hexakisphosphate kinase-2, Proc Natl Acad Sci U S A, 107, 20947, 10.1073/pnas.1015671107 · DOI · Paper page
  27. BH Morrison, 2001, Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells, J Biol Chem, 276, 24965, 10.1074/jbc.M101161200 · DOI · Paper page
  28. C Illies, 2007, Requirement of inositol pyrophosphates for full exocytotic capacity in pancreatic beta cells, Science, 318, 1299, 10.1126/science.1146824 · DOI · Paper page
  29. A Chakraborty, 2010, Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain, Cell, 143, 897, 10.1016/j.cell.2010.11.032 · DOI · Paper page
  30. A Prasad, 2011, Inositol hexakisphosphate kinase 1 regulates neutrophil function in innate immunity by inhibiting phosphatidylinositol-(3,4,5)-trisphosphate signaling, Nat Immunol, 12, 752, 10.1038/ni.2052 · DOI
  31. RA Bozym, 2012, Focal adhesion kinase is a component of antiviral RIG-I-like receptor signaling, Cell Host Microbe, 11, 153, 10.1016/j.chom.2012.01.008 · DOI
  32. KH Kok, 2011, The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response, Cell Host Microbe, 9, 299, 10.1016/j.chom.2011.03.007 · DOI · Paper page
  33. J Zhu, 2010, High-throughput screening for TLR3-IFN regulatory factor 3 signaling pathway modulators identifies several antipsychotic drugs as TLR inhibitors, J Immunol, 184, 5768, 10.4049/jimmunol.0903559 · DOI
  34. Y Li, 2013, Protein kinase regulated by dsRNA downregulates the interferon production in dengue virus- and dsRNA-stimulated human lung epithelial cells, PLoS One, 8, e55108, 10.1371/journal.pone.0055108 · DOI
  35. K Yang, 2009, TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response, J Immunol, 182, 3782, 10.4049/jimmunol.0803126 · DOI · Paper page
  36. CR Bolen, 2013, The blood transcriptional signature of chronic hepatitis C virus is consistent with an ongoing interferon-mediated antiviral response, J Interferon Cytokine Res, 33, 15, 10.1089/jir.2012.0037 · DOI
  37. M Caskey, 2011, Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans, J Exp Med, 208, 2357, 10.1084/jem.20111171 · DOI · Paper page
  38. S Indraccolo, 2007, Identification of genes selectively regulated by IFNs in endothelial cells, J Immunol, 178, 1122, 10.4049/jimmunol.178.2.1122 · DOI · Paper page
  39. BJ Fenner, 2010, Expanding the substantial interactome of NEMO using protein microarrays, PLoS One, 5, e8799, 10.1371/journal.pone.0008799 · DOI
  40. SM Belgnaoui, 2012, Linear ubiquitination of NEMO negatively regulates the interferon antiviral response through disruption of the MAVS-TRAF3 complex, Cell Host Microbe, 12, 211, 10.1016/j.chom.2012.06.009 · DOI
  41. SB Shears, 2011, Diphosphoinositol polyphosphates: what are the mechanisms?, Adv Enzyme Regul, 51, 13, 10.1016/j.advenzreg.2010.09.008 · DOI
  42. CJ Barker, 2009, Inositol pyrophosphates: structure, enzymology and function, Cell Mol Life Sci, 66, 3851, 10.1007/s00018-009-0115-2 · DOI
  43. M Bennett, 2006, Inositol pyrophosphates: metabolism and signaling, Cell Mol Life Sci, 63, 552, 10.1007/s00018-005-5446-z · DOI · Paper page
  44. JH Choi, 2007, Purification, sequencing, and molecular identification of a mammalian PP-InsP5 kinase that is activated when cells are exposed to hyperosmotic stress, J Biol Chem, 282, 30763, 10.1074/jbc.M704655200 · DOI · Paper page
  45. PC Fridy, 2007, Cloning and characterization of two human VIP1-like inositol hexakisphosphate and diphosphoinositol pentakisphosphate kinases, J Biol Chem, 282, 30754, 10.1074/jbc.M704656200 · DOI · Paper page
  46. S Mulugu, 2007, A conserved family of enzymes that phosphorylate inositol hexakisphosphate, Science, 316, 106, 10.1126/science.1139099 · DOI · Paper page
  47. T Wundenberg, 2012, Synthesis and biological actions of diphosphoinositol phosphates (inositol pyrophosphates), regulators of cell homeostasis, Biol Chem, 393, 979, 10.1515/hsz-2012-0133 · DOI
  48. R Bhandari, 2008, Gene deletion of inositol hexakisphosphate kinase 1 reveals inositol pyrophosphate regulation of insulin secretion, growth, and spermiogenesis, Proc Natl Acad Sci U S A, 105, 2349, 10.1073/pnas.0712227105 · DOI · Paper page
  49. Z Szijgyarto, 2011, Influence of inositol pyrophosphates on cellular energy dynamics, Science, 334, 802, 10.1126/science.1211908 · DOI · Paper page
  50. U Padmanabhan, 2009, Characterization of a selective inhibitor of inositol hexakisphosphate kinases: use in defining biological roles and metabolic relationships of inositol pyrophosphates, J Biol Chem, 284, 10571, 10.1074/jbc.M900752200 · DOI · Paper page
  51. RS Kilari, 2013, Understanding inositol pyrophosphate metabolism and function: kinetic characterization of the DIPPs, FEBS Lett, 587, 3464, 10.1016/j.febslet.2013.08.035 · DOI
  52. A Lonetti, 2011, Identification of an evolutionarily conserved family of inorganic polyphosphate endopolyphosphatases, J Biol Chem, 286, 31966, 10.1074/jbc.M111.266320 · DOI · Paper page
  53. W Zeng, 2009, Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3, Mol Cell, 36, 315, 10.1016/j.molcel.2009.09.037 · DOI · Paper page
  54. JD Weaver, 2012, The kinetic properties of a human PPIP5K reveal that its kinase activities are protected against the consequences of a deteriorating cellular bioenergetic environment, Biosci Rep, 33, pii: e00022, 10.1042/BSR20120115 · DOI · Paper page
  55. C Azevedo, 2009, Inositol pyrophosphate mediated pyrophosphorylation of AP3B1 regulates HIV-1 Gag release, Proc Natl Acad Sci U S A, 106, 21161, 10.1073/pnas.0909176106 · DOI · Paper page
  56. R Bhandari, 2007, Protein pyrophosphorylation by inositol pyrophosphates is a posttranslational event, Proc Natl Acad Sci U S A, 104, 15305, 10.1073/pnas.0707338104 · DOI · Paper page
  57. AM Riley, 2012, First synthetic analogues of diphosphoinositol polyphosphates: interaction with PP-InsP5 kinase, Chem Commun (Camb), 48, 11292, 10.1039/c2cc36044f · DOI
  58. C Jin, 2013, Innate sensors of pathogen and stress: linking inflammation to obesity, J Allergy Clin Immunol, 132, 287, 10.1016/j.jaci.2013.06.022 · DOI · Paper page
  59. H Wang, 2012, Structural basis for an inositol pyrophosphate kinase surmounting phosphate crowding, Nat Chem Biol, 8, 111, 10.1038/nchembio.733 · DOI · Paper page
  60. YS Lee, 2007, Regulation of a cyclin-CDK-CDK inhibitor complex by inositol pyrophosphates, Science, 316, 109, 10.1126/science.1139080 · DOI · Paper page
  61. A Saiardi, 2004, Phosphorylation of proteins by inositol pyrophosphates, Science, 306, 2101, 10.1126/science.1103344 · DOI · Paper page
  62. T Kawasaki, 2013, The second messenger phosphatidylinositol-5-phosphate facilitates antiviral innate immune signaling, Cell Host Microbe, 14, 148, 10.1016/j.chom.2013.07.011 · DOI
  63. N Rieber, 2009, RNAither, an automated pipeline for the statistical analysis of high-throughput RNAi screens, Bioinformatics, 25, 678, 10.1093/bioinformatics/btp014 · DOI · Paper page
  64. B Manicassamy, 2010, Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus, Proc Natl Acad Sci U S A, 107, 11531, 10.1073/pnas.0914994107 · DOI · Paper page
  65. T Iwamura, 2001, Induction of IRF-3/-7 kinase and NF-kappaB in response to double-stranded RNA and virus infection: common and unique pathways, Genes Cells, 6, 375, 10.1046/j.1365-2443.2001.00426.x · DOI · Paper page
  66. O Loss, 2011, Preparation of quality inositol pyrophosphates, J Vis Exp, e3027
  67. M Hoenig, 1989, A microtiter plate assay for inorganic phosphate, J Biochem Biophys Methods, 19, 249, 10.1016/0165-022X(89)90031-6 · doi:10.1016/0165-022x(89)90031-6

Cited by

See all 72

Metadata

Authors
Pulloor, N. K., Nair, S., Kostic, A. D., Bist, P., Weaver, J. D., Riley, A. M., Tyagi, R., Uchil, P. D., York, J. D., Snyder, S. H., García-Sastre, A., Potter, B. V. L., Lin, R., Shears, S. B., Xavier, R. J., & Krishnan, M. N.
Venue
PLoS Pathogens
Published
2014-02-27
Volume
10
Issue
2
Pages
e1003981
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W2162432199
Cited by
72
References
5
FWCI
5.45
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response. https://app.cochat.ai/papers/10.1371/journal.ppat.1003981
The paper
Pulloor, N. K., Nair, S., Kostic, A. D., Bist, P., Weaver, J. D., Riley, A. M., Tyagi, R., Uchil, P. D., York, J. D., Snyder, S. H., García-Sastre, A., Potter, B. V. L., Lin, R., Shears, S. B., Xavier, R. J., & Krishnan, M. N. (2014). Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response. PLoS Pathogens. https://doi.org/10.1371/journal.ppat.1003981

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.